ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Volatile Stock Indices require careful risk management and agile tactics. This view helps you adapt strategies to sudden price moves and liquidity shifts.
19,564 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
As streaming shifts accelerate, FuboTV's 2026 earnings outlook hinges on subscriber growth, ad revenue, and content c...
When Berkshire Hathaway keeps a stake in a company for decades, you want to listen. american express just showed why ...
Apple and Microsoft posted strong earnings as the AI battle tightens. Microsoft leads on monetizing generative AI, wh...
PEY sits at a crossroads, pairing long-running dividend growers with higher-yielding, potentially riskier payors. As ...
As Wrap Technologies moves through 2026, the Q1 results shed light on demand for its WRAP security platform. This gui...
Barclays boosts its view on Charles Schwab after the firm guides for higher 2026 revenue and reports stronger Q1 resu...
Protests ignite in Nairobi as fuel costs surge and a transport strike widens disrupted daily life; schools shift onli...
Synopsys posted a strong Q1 FY2026 showing AI-enabled design work driving revenue and backlog, fueling bets the stock...
A high-profile hedge fund billionaire made bold moves, piling into Amazon and Microsoft while slashing a top AI stock...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...